" class="no-js "lang="en-US"> Kieran Seyan - Medtech Alert
Monday, May 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Kieran Seyan

Kieran Seyan

About Kieran Seyan

Dr Kieran Seyan has worked for Online Doctor since 2015 and is the Medical Director, overseeing all clinical practice and prescribing. After qualifying, he worked in a range of GP practices and hospitals, gaining experience in general practice, urgent care and sexual health medicine. He still works as a locum GP in the Hertfordshire area.

Related Story

Health Apps

 LloydsPharmacy Expands Digital Healthcare Offering with New VideoGP Service | Pharmtech Focus

LloydsPharmacy Expands Digital Healthcare Offering with New VideoGP Service

September 7 2021

LloydsPharmacy has today (Wednesday 25th August) launched a VideoGP app that provides access to an experienced […]